S erum cortisol concentrations increase dramatically and rapidly in the early phase of acute critical illness (1) . Such a response is necessary, for example, to mobilize energy stores and protect against excessive inflammation. Higher random cortisol concentrations have been associated with increased case fatality from critical illness (2, 3) , consistent with a greater stress response during more severe underlying illness. However, in some patients, low random cortisol is associated with increased risk of death (2) ; this group may overlap with those considered to have "relative adrenal insufficiency" on the basis of an impaired incremental response to exogenous adrenocorticotropic hormone (3) . Most studies have included patients with diverse underlying diseases, who may have been receiving drug treatment that could interfere with the hypothalamic-pituitaryadrenal axis, such as etomidate (1) . In small case series of myocardial infarction, relatively low cortisol concentrations have been associated with both increased (4) and decreased (5-7) case fatality. Relative adrenal insufficiency has also been postulated as contributing to morbidity and case fatality among patients suffering shock after cardiopulmonary arrest (8) . We have explored the association between admission serum cortisol concentrations and 30-day case fatality in a cohort of patients presenting with acute myocardial infarction.
MATERIALS AND METHODS
We previously undertook a prospective cohort study in which we recruited 2806 patients admitted with acute myocardial infarction to nine hospitals over 10 months, from June 2005 to March 2006 inclusive (9) . Acute myocardial infarction was defined according to the Universal Definition of Myocardial Infarction (10) . We used probabilistic record linkage methods to link our baseline data to death certificate data to determine which patients died after admission and their date of death. We randomly selected 100 patients who died within 30 days of admission (cases) and 100 who were still alive at 30 days follow-up (controls). Socioeconomic status was measured by using population quintiles of the Scottish Index of Multiple Deprivation index for the participant's usual place of residence (http:// www.scotland.gov.uk/Topics/Statistics/SIMD/). Residual sera from clinical samples taken on admission to hospital were stored at Ϫ80°C and used to measure cortisol concentrations by radioimmunoassay (MP Biomedicals, Cambridge, UK) (intra-assay coefficient of variation, 5.1% to 7.0%; interassay coefficient of variation, 6.0% to 7.9%). Admission cortical concentration was categorized, using quartiles, and logistic regression analysis was used to determine whether cortisol quartile was associated with the risk of death within 30 days. All statistical analyses were performed with use of SPSS software for Windows, version 13.0 (SPSS, Chicago, IL). The study was approved by the West Glasgow Research Ethics Committee. Design: Nested case-control study. Setting: Prospective cohort study of consecutive patients admitted with acute myocardial infarction to nine Scottish hospitals.
Patients: A total of 100 patients who survived 30 days (controls) and 100 patients who died within 30 days (cases). 
Measurements and Main Results

RESULTS
Among the 200 patients selected at random, sufficient residual serum was available for 177. Of these, 80 had died within 30 days of admission and 97 were still alive. Those patients who had died had significantly lower admission serum cortisol concentrations (median, 1189 nmol/L; interquartile range, 957-1373 nmol/L) than those who survived (median, 1355 nmol/L; interquartile range, 1240 -1561 nmol/L) (Mann-Whitney U test, p Ͻ .001) and were significantly older (Table 1) . On univariate logistic regression analysis, there was a negative association between cortisol concentration and risk of death, with evidence of a threshold effect (Fig. 1) . Compared with patients whose cortisol concentration was in the top quartile (Ͼ1437 nmol/L), those in the lowest quartile (Ͻ1136 mmol/L) had a greater risk of death (odds ratio, 10.39; 95% confidence interval, 3.87-27.91; p Ͻ .001) ( Fig. 1 ).
There were no significant differences between the dead and alive groups in terms of sex (male 56% vs. 58%, chi-square test, p ϭ .807) or in the breakdown by Scottish Index of Multiple Deprivation quintile (chi-square test for trend, p ϭ .586). Those who died were significantly older (median, 77 yrs; interquartile range, 71-84 yrs) than survivors (median, 68 yrs; interquartile range, 54 -79 yrs) (Mann-Whitney U test, p Ͻ .001), and increasing age was a significant predictor of risk of death (unadjusted odds ratio for 1-yr increase in age, 1.07; 95% confidence interval, 1.04 -1.10; p Ͻ .001). After adjusting for age as a potential confounder, the lowest cortisol quartile was still significantly associated with increased risk of death (adjusted odds ratio, 9.37; 95% confidence interval, 3.32-26.40; p Ͻ .001) (Fig. 1) . There was no significant difference between the dead and alive groups with regard to troponin concentration (Mann-Whitney U test, p ϭ .132) and adjustment for troponin only slightly attenuated the association between cortisol and risk of death (adjusted odds ratio, 8.78; 95% confidence interval, 3.09 -24.96; p Ͻ .001).
DISCUSSION
As previously reported (5) , admission serum cortisol concentrations were raised after acute myocardial infarction by a magnitude in keeping with other severe acute illnesses. However, cortisol concentrations were significantly lower among patients who subsequently died compared with those who survived. Adrenocorticotropic hormone stimulation tests were not undertaken in this cohort, so the criteria for "relative adrenal insufficiency" identified in previous studies of critical illness cannot be applied (3). Nonetheless, our results suggest that inability of the hypothalamic-pituitaryadrenal axis to mount a full stress response is associated with adverse outcomes not only in patients with multiple organ failure due to trauma or sepsis but also in those with acute myocardial infarction.
Previous studies of the association between cortisol concentration and prognosis after acute myocardial infarction are few and results are conflicting. A previous study of just 34 patients also reported a negative association between cortisol concentration and risk of death (4). By contrast, three small studies of between 22 and 70 patients with few deaths suggested increased risk of death among patients with high cortisol concentrations (5) (6) (7) . It is possible that subgroups of patients exist in whom either very high or very low cortisol confers an adverse prognosis in acute myocardial infarction, as in more heterogeneous critical illness (2) . However, in our study, which comprised substantially larger number of deaths than any previous study, we found no evidence of increased risk of death among patients with high serum cortisol concentrations.
In the association we demonstrated between low cortisol concentration and increased risk of case fatality, we cannot exclude the possibility of residual confounding. We lacked data on a number of factors that vary with cortisol concentration, such as renal dysfunction and corticosteroid-binding globulin. We were able to demonstrate that the association between cortisol and survival was independent of the potential confounding effects of age and troponin concentration. Larger infarct size is positively associated with both higher cortisol concentration (5) and greater risk of death. Therefore, had we been able to adjust for infarct size, this could only have increased the association between low cortisol concentration and increased risk of death. Cortisol concentration may be causally related to blood pressure, glucose, and lipid levels-all of which could therefore act as potential mediators of the association between low cortisol and risk of death. However, in the absence of data, we were unable to explore these possible mechanisms.
CONCLUSIONS
Low cortisol concentration on admission is an adverse prognostic indicator in patients with acute myocardial infarction, as it is in critically ill patients after sepsis or trauma. Further studies are required to corroborate our findings, adjust for potential residual confounders, establish the underlying mechanisms, determine the prevalence of relative adrenal insufficiency as defined by adrenocorticotropic hormone-stimulation testing, and establish the therapeutic value of glucocorticoid replacement therapy in patients with relatively impaired cortisol responses.
